Anaesthesia and pain, Guidance

Applied filters

Care Setting (2)
- Neonates (1)
- Palliative and End of Life Care (1)
Guidance (88)
- Aseptic services (10)
- Intrathecal medicines (10)
- Safety in Breastfeeding (75)
- Safety in Pregnancy (2)
- Switching (1)
- Temperature management (6)
  - Stability outside the fridge (6)
Medicine (87)
- Aceclofenac (2)
- Acemetacin (2)
- Alfentanil (2)
- Almotriptan (2)
- Aspirin (1)
- Atracurium (2)
- Atropine (1)
- Botulinum A toxin (1)
- Bupivacaine (3)
- Buprenorphine (3)
- Capsaicin (1)
- Celecoxib (2)
- Cisatracurium (2)
- Clonidine (3)
- Co-codamol (1)
- Co-dydramol (1)
- Codeine (3)
- Dantrolene (1)
- Dexketoprofen (2)
- Dexmedetomidine (2)
- Diamorphine (2)
- Diazepam (2)
- Diclofenac sodium (2)
- Dihydrocodeine (3)
- Dihydrocodeine + Paracetamol (1)
- Edrophonium (1)
- Eletriptan (2)
- Erenumab (1)
- Ergotamine (1)
- Etodolac (2)
- Etoricoxib (2)
- Fentanyl (3)
- Flurbiprofen (2)
- Fremanezumab (1)
- Frovatriptan (2)
- Galcanezumab (1)
- Glycopyrronium (1)
- Hydromorphone (3)
- Hyoscine hydrobromide (1)
- Ibuprofen (3)
- Indometacin (2)
- Isoflurane (2)
- Ketamine (2)
- Ketoprofen (2)
- Levobupivacaine (3)
- Lidocaine (4)
- Lorazepam (2)
- Mefenamic acid (2)
- Meloxicam (2)
- Methadone (1)
- Midazolam (2)
- Morphine (4)
- Nabumetone (2)
- Naloxone (1)
- Naproxen (2)
- Naratriptan (2)
- Nefopam (1)
- Neostigmine (1)
- Nitrous oxide gas (2)
- Oxycodone (3)
- Pancuronium (2)
- Paracetamol (2)
- Paracetamol + Codeine + Buclizine (1)
- Paracetamol + Dihydrocodeine (1)
- Pethidine (1)
- Phenol (1)
- Piroxicam (2)
- Pizotifen (1)
- Propofol (2)
- Proxymetacaine (1)
- Rizatriptan (2)
- Rocuronium (2)
- Ropivacaine (1)
- Sumatriptan (2)
- Suxamethonium (2)
- Tapentadol (2)
- Temazepam (2)
- Tenoxicam (1)
- Tetracaine (3)
- Tizanidine (1)
- Tolfenamic acid (1)
- Tramadol (3)
- Tramadol + Paracetamol (1)
- Ziconotide (1)
- Zolmitriptan (2)
Medicines planning (29)
- New Medicines (14)
  - CCG commissioned new medicines (13)
  - NHS England commissioned new medicines (1)
  - Pre-registration new medicines (UK/EU) (2)
- Patent expiries (23)
Specialty (88)
- Anaesthesia and pain (88)
- Cancers (1)
- Cardiovascular system disorders (3)
- Ear, nose and throat disorders (1)
- Eyes and vision (5)
- Gastrointestinal disorders (1)
- Mental health and illness (11)
- Musculo-skeletal disorders (22)
- Neurological disorders (13)
- Obstetrics and gynaecology (1)
- Respiratory disorders (1)
- Skin disorders (2)
- Surgery (2)

Using strong opioid analgesics during breastfeeding

26 May 2023Morphine is the strong opioid analgesic of choice for treating pain in breastfeeding. Recommendations apply to full term and healthy infants only.

Using codeine, dihydrocodeine or tramadol during breastfeeding

17 January 2023Tramadol and dihydrocodeine can be used while breastfeeding for pain control. Codeine should not be used . Advice applies to full term, healthy infants.

Morphine products: information for supporting intrathecal risk assessment

11 August 2022Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Phenol products: information for supporting intrathecal risk assessment

11 August 2022Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ropivacaine products: information for supporting intrathecal risk assessment

11 August 2022Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Lidocaine products: information for supporting intrathecal risk assessment

11 August 2022Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Diamorphine hydrochloride products: information for supporting intrathecal risk assessment

11 August 2022Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydromorphone products: information for supporting intrathecal risk assessment

11 August 2022Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Bupivacaine products: information for supporting intrathecal risk assessment

11 August 2022Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ziconotide products: information for supporting intrathecal risk assessment

11 August 2022Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

SPS - Specialist Pharmacy Service

NHS